Related Experiment Video
Updated: Mar 27, 2026
09:02
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
22.7K
Prognostic Factors for Chronic Lymphocytic Leukemia.
Christopher Chen1, Soham Puvvada2
1, 1515 N Campbell Ave., Tucson, AZ, 85724, USA. cmchen@email.arizona.edu.
Current Hematologic Malignancy Reports
|January 11, 2016
Summary
Updated prognostic markers for chronic lymphocytic leukemia (CLL) offer improved patient assessment beyond traditional Rai and Binet systems. Key factors include genetic, biochemical, and patient characteristics for better treatment and prognostication.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Chronic lymphocytic leukemia (CLL) management relies on prognostic staging.
- Traditional Rai and Binet staging systems are being enhanced by new markers.
Purpose of the Study:
- To review and summarize modern prognostic factors for CLL patients.
- To update prognostication strategies with current research.
Main Methods:
- Systematic review of recent literature from major CLL research centers.
- Categorization of prognostic factors into genetic, biochemical/cell surface, and patient characteristics.
Main Results:
- Genetic factors: 17p deletion, 11q deletion, and immunoglobulin heavy chain variable (IGHV) mutations.
- Biochemical/cell surface markers: serum thymidine kinase, β-2-microglobulin, CD49d, CD38, and ZAP-70.
- Patient characteristics: sex, age, and performance status are also significant.
Conclusions:
- Modern prognostic markers provide a more refined assessment of CLL.
- Integrating these factors can improve treatment strategies and patient prognostication.
More Related Videos
Related Concept Videos
01:16Primary Lymphoid Organs
16.6K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
16.6K
01:27Disorders of Leukocytes
2.4K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.4K